Clinical Trial Update: Evaluation of the Effects of Urotensin-II and Soluble Epoxide Hydrolase Inhibitors on Skin Microvessel Tone in Patients With Heart Failure, and in Healthy Volunteers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effects of urotensin-II and soluble epoxide hydrolase inhibitors on skin microvessel tone in heart failure patients (and healthy vo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Soluble epoxide hydrolase inhibitor
• Urotensin-II (urotensin II)

Snippet

Sponsor: Monash University | Conditions: Heart Failure | Phase 2 | Status: COMPLETED